A major trial in India has taken centre-stage at the American Society of Clinical Oncology meeting in Chicago after it demonstrated that a simple test using vinegar has slashed the rates of cervical cancer mortality in the country.
News
BioMarin gets US priority review for rare disease drug
BioMarin will be celebrating news that regulators on both sides of the Atlantic have agreed to review Vimzin under accelerated review processes.
FDA refuses approval for Endo’s Aveed again
Shares in Endo Health Solutions took a downturn in after-hours trading last night after it emerged that US regulators have again refused to approve its testosterone injection.
Indiana unveils public-private life sciences research institute
Life sciences companies and research universities in Indiana have come together to establish the country’s first industry-led collaborative life sciences research institute which, it is hoped, will fuel innovation and bring new jobs and investment to the region.
Japan launches $100m initiative to develop drugs for poorest nations
A ground-breaking new initiative has been launched Japan which will see the government, universities and the pharmaceutical sector band together to develop new medicines for diseases affecting the developing world.
Long term painkiller use linked to heart risk
Common pain drugs can increase the risk of heart problems when taken over a long period, with smokers and the obese particularly at risk.
Lucentis rival one step away from NHS approval
NICE is recommending Bayer’s wet age related macular oedema drug Eylea in a speedy review published today.
UK launch for Gilead’s four-in-one HIV pill
Gilead’s new once-daily, single pill HIV therapy Stribild has been rolled out in the UK this week, offering potential benefits in treatment adherence, a crucial aspect of treatment outcomes.
US approval for GSK melanoma drugs
GlaxoSmithKline has received US approval for its two melanoma pills and a companion diagnostic made by French firm bioMérieux.
Cedars-Sinai registry seeks increased female engagement in cancer trials
A new online registry launched by Cedars-Sinai Medical Center, the non-profit hospital and academic health science institution in Los Angeles, US, is looking to boost women’s participation in oncology clinical research.
Environment Committee adopts Willmott amendments to CT regulation
The European Parliament’s Committee on Environment and Public Health has unanimously adopted rapporteur Glenis Willmott’s amendments to the Commission’s proposed regulation on clinical trials, including provisions requiring sponsors to publish full Clinical Study Reports once a marketing-authorisation decision has been taken.
EU-LIFE alliance to raise profile of European life-sciences research
A new alliance of 10 leading life-science institutes aims to raise the international profile of European research and develop co-ordinated responses to the challenges facing the sector.
Germany: “EU’s most favourable market for biosimilars”
A study of five European Union (EU) nations finds that Germany provides the most favourable environment for biosimilar drugs, while Italy is the least favourable.
GSK strengthens vaccines business with Okairos buy
GlaxoSmithKline has purchased the Swiss-based vaccine technology company Okairos for 250 million euros in a deal that will bolster the firm’s biologics division.
NICE FAD OKs first-in-class diabetes drug Forxiga
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) backing the use of Bristol-Myers Squibb (BMS)/AstraZeneca’s first-in-class type 2 diabetes treatment Forxiga (dapagliflozin).
